p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is associated with the cleavage of the amyloid precursor protein (APP) to produce the toxic amyloid-β (Aβ) peptide. Accumulation of Aβ, together with the concomitant inflammatory response, ultimately leads to neuronal death and cognitive decline. Despite AD progression being underpinned by both neuronal and immunological components, therapeutic strategies based on dual targeting of these systems remains unexplored. Here, we report that inactivation of the p110δ isoform of phosphoinositide 3-kinase (PI3K) reduces anterograde axonal trafficking of APP in hippocampal neurons and dampens secretion of the inflammatory cytokine tumor necrosis factor-alpha by microglial cells in the familial AD APP swe/PS1 ΔE9(APP/PS1) mouse model. Moreover, APP/PS1 mice with kinase-inactive PI3Kδ (δ D910A) had reduced Aβ peptides levels and plaques in the brain and an abrogated inflammatory response compared with APP/PS1 littermates. Mechanistic investigations reveal that PI3Kδ inhibition decreases the axonal transport of APP by eliciting the formation of highly elongated tubular-shaped APP-containing carriers, reducing the levels of secreted Aβ peptide. Importantly, APP/PS1/δ D910A mice exhibited no spatial learning or memory deficits. Our data highlight inhibition of PI3Kδ as a new approach to protect against AD pathology due to its dual action of dampening microglial-dependent neuroinflammation and reducing plaque burden by inhibition of neuronal APP trafficking and processing. SIGNIFICANCE STATEMENT During Alzheimer's disease (AD), the accumulation of the toxic amyloid-β (Aβ) peptide in plaques is associated with a chronic excessive inflammatory response. Uncovering new drug targets that simultaneously reduce both Aβ plaque load and neuroinflammation holds therapeutic promise. Using a combination of genetic and pharmacological approaches, we found that the p110δ isoform of phosphoinositide 3-kinase (PI3K) is involved in anterograde trafficking of the amyloid precursor protein in neurons and in the secretion of tumor necrosis factor-alpha from microglial cells. Genetic inactivation of PI3Kδ reduces Aβ plaque deposition and abrogates the inflammatory response, resulting in a complete rescue of the life span and spatial memory performance. We conclude that inhibiting PI3Kδ represents a novel therapeutic approach to ameliorate AD pathology by dampening plaque accumulation and microglial-dependent neuroinflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the axonal APP transport has been shown to be regulated by the phosphoinositide 3-kinase (PI3K), PI3Kδ”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [87]
In the citing paper
“expression of the dominant-negative inactive PI3Kδ induced the formation of tubular APP carriers with bi-directional movement and reduced APP transport in the axon”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: APP binds DR6 to trigger axon pruning and neuron death via distinct caspases
Nikolaev, A., McLaughlin, T., O’Leary, D. D. M., & Tessier-Lavigne, M. (2009) · Nature · doi:10.1038/nature07767 · Cited by 992 · cited 2×
“Based on the notion that TNF and APP share structural similarities and are both recognized as members of the TNF receptor superfamily (Nikolaev et al., 2009), we investigated whether APP trafficking in neurons could also be regulated by PI3K .”
BackgroundRetractedNeurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Microglia Function in the Central Nervous System During Health and Neurodegeneration
Colonna, M., & Butovsky, O. (2017) · Annual Review of Immunology · doi:10.1146/annurev-immunol-051116-052358 · Cited by 2,894
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 2×
“However, at later stages of disease, excess TNF levels in the brain in response to amyloid aggregates and fibrils can inhibit the microglial clearance of A (Hickman et al., 2008), inducing surrounding astrocytes into a toxic “A1” state that causes neuronal death (Liddelow et al.”
BackgroundEl Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915
TGF-β1 promotes microglial amyloid-β clearance and reduces plaque burden in transgenic mice
Wyss-Coray, T., Lin, C., Yan, F., Yu, G.-Q., Rohde, M., McConlogue, L., Masliah, E., & Mucke, L. (2001) · Nature Medicine · doi:10.1038/87945 · Cited by 587
Intrathecal inflammation precedes development of Alzheimer's disease
Tarkowski, E. (2003) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.9.1200 · Cited by 501 · cited 4×
“, 1991) and CSF (Tarkowski et al., 2003) of patients with AD, we found that the brain level of TNF was increased in APP/PS1 mice.”
BackgroundInfluentialLiao, Y.-F., Wang, B.-J., Cheng, H.-T., Kuo, L.-H., & Wolfe, M. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402034200 · Cited by 389 · cited 1×
“Furthermore, elevated TNF levels promote A production (Liao et al., 2004), thereby driving a vicious cycle of chronic neuroinflammation and disease progression.”
BackgroundHaure-Mirande, J.-V., Audrain, M., Fanutza, T., Kim, S. H., Klein, W. L., Glabe, C., Readhead, B., Dudley, J. T., Blitzer, R. D., Wang, M., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1737-3 · Cited by 127 · cited 1×
“Interestingly, genetic downregulation of TYROBP/DAP12 exerts a similar protective effect in the same mouse model (APP/ PS1) of AD (Haure-Mirande et al., 2017).”
BackgroundWhitesell, J. D., Buckley, A. R., Knox, J. E., Kuan, L., Graddis, N., Pelos, A., Mukora, A., Wakeman, W., Bohn, P., Ho, A., et al. (2019) · Journal of Comparative Neurology · doi:10.1002/cne.24555 · Cited by 99
Research works printed but not linked: 48
- 10.1038/nature13444 · DOI · Paper page
- 10.1073/pnas.0503689102 · DOI · Paper page
- 10.1038/mp.2008.96 · DOI · Paper page
- 10.1038/nn.2801 · DOI · Paper page
- 10.1016/j.nbd.2013.10.007 · DOI
- Bilanges B , Posor Y , Vanhaesebroeck B (2019) PI3K isoforms in cell signalling and vesicle trafficking. Nat Rev Mol Cell Biol. In press. · DOI · Paper page
- 10.1523/JNEUROSCI.4814-07.2008 · DOI · Paper page
- 10.1016/j.nbd.2006.06.007 · DOI · Paper page
- 10.1016/j.drudis.2014.06.029 · DOI
- 10.1002/1096-8628(20001204)96:6<823::AID-AJMG26>3.0.CO;2-I · DOI
- 10.1097/00005072-199704000-00001 · DOI · Paper page
- 10.1111/1440-1681.12277 · DOI
- 10.1371/journal.pone.0000869 · DOI
- 10.1016/j.neurobiolaging.2014.05.023 · DOI
- 10.1016/0304-3940(91)90490-K · DOI · Paper page
- 10.1056/NEJMoa1315226 · DOI · Paper page
- 10.1371/journal.pone.0018754 · DOI · Paper page
- 10.1016/j.bmcl.2016.10.069 · DOI
- 10.1093/hmg/ddz144 · DOI
- 10.1523/JNEUROSCI.4595-08.2009 · DOI · Paper page
- 10.1016/j.neurobiolaging.2003.09.008 · DOI · Paper page
- 10.1101/lm.70104 · DOI · Paper page
- 10.1186/1742-2094-5-23 · DOI · Paper page
- 10.1038/nprot.2017.116 · DOI
- 10.1038/35055042 · DOI · Paper page
- 10.1186/1756-6606-5-25 · DOI
- 10.1038/ng.2802 · DOI · Paper page
- 10.1080/13543784.2017.1384815 · DOI
- 10.1182/blood-2010-03-275305 · DOI · Paper page
- 10.1083/jcb.201001028 · DOI
- 10.1038/ncomms4450 · DOI
- 10.2174/187152710791012071 · DOI · Paper page
- 10.1523/JNEUROSCI.5215-08.2009 · DOI · Paper page
- 10.1016/j.yexcr.2014.12.014 · DOI
- 10.1038/nri1056 · DOI · Paper page
- 10.1126/science.1073560 · DOI · Paper page
- 10.1016/j.neurobiolaging.2006.08.014 · DOI · Paper page
- 10.1016/j.neurobiolaging.2016.07.028 · DOI · Paper page
- 10.1016/j.bcp.2014.01.011 · DOI · Paper page
- 10.1038/nmeth.2019 · DOI · Paper page
- 10.1074/jbc.M705073200 · DOI · Paper page
- 10.1126/science.1074069 · DOI · Paper page
- 10.1038/onc.2009.503 · DOI
- 10.1126/science.1105681 · DOI · Paper page
- 10.1016/j.ymeth.2016.09.016 · DOI · Paper page
- 10.1002/ana.20101 · DOI · Paper page
- 10.1002/jnr.1097 · DOI
- 10.1101/gad.257675.114 · DOI
Cited by
PI3K inhibitors are finally coming of age
Vanhaesebroeck, B., Perry, M. W. D., Brown, J. R., André, F., & Okkenhaug, K. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00209-1 · Cited by 476
Self-citationDysregulated phosphoinositide 3-kinase signaling in microglia: shaping chronic neuroinflammation
Chu, E., Mychasiuk, R., Hibbs, M. L., & Semple, B. D. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02325-6 · Cited by 152
Chaudry, O., Ndukwe, K., Xie, L., Figueiredo-Pereira, M., Serrano, P., & Rockwell, P. (2022) · Scientific Reports · doi:10.1038/s41598-022-23801-w · Cited by 28
Wang, J., Fourriere, L., & Gleeson, P. A. (2024) · Biochemical Journal · doi:10.1042/bcj20240056 · Cited by 27
Metadata
- Authors
- Martínez-Mármol, R., Mohannak, N., Qian, L., Wang, T., Gormal, R. S., Ruitenberg, M. J., Vanhaesebroeck, B., Coulson, E. J., & Meunier, F. A.
- ORCID
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2019-07-30
- Volume
- 39
- Issue
- 40
- Pages
- 7976-7991
- ISSN
- 0270-6474
- 1529-2401
- Cited by
- 28
- References
- 12
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model. https://app.cochat.ai/papers/10.1523/jneurosci.0674-19.2019
- The paper
- Martínez-Mármol, R., Mohannak, N., Qian, L., Wang, T., Gormal, R. S., Ruitenberg, M. J., Vanhaesebroeck, B., Coulson, E. J., & Meunier, F. A. (2019). p110δ PI3-Kinase Inhibition Perturbs APP and TNFα Trafficking, Reduces Plaque Burden, Dampens Neuroinflammation, and Prevents Cognitive Decline in an Alzheimer's Disease Mouse Model. The Journal of Neuroscience. https://doi.org/10.1523/jneurosci.0674-19.2019
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.